Lineage Cell Therapeutics In shares owned by Scotia Capital
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Scotia Capital
from 13F filings
Historical chart of Scotia Capital investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Scotia Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Scotia Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $18k | 17k | 1.09 |
| 2023-09-30 | $20k | 17k | 1.18 |
| 2023-06-30 | $24k | 17k | 1.41 |
| 2023-03-31 | $25k | 17k | 1.50 |
| 2022-12-31 | $20k | 17k | 1.17 |
| 2022-09-30 | $38k | 34k | 1.13 |
| 2022-06-30 | $53k | 34k | 1.58 |
| 2022-03-31 | $52k | 34k | 1.54 |
| 2021-12-31 | $82k | 34k | 2.45 |
| 2021-09-30 | $85k | 34k | 2.52 |
| 2021-06-30 | $95k | 34k | 2.84 |
| 2021-03-31 | $79k | 34k | 2.36 |
| 2020-12-31 | $59k | 34k | 1.76 |
| 2020-09-30 | $31k | 33k | 0.94 |
| 2020-06-30 | $29k | 34k | 0.87 |
| 2020-03-31 | $39k | 47k | 0.84 |
| 2019-12-31 | $30k | 34k | 0.90 |
| 2019-09-30 | $33k | 34k | 0.99 |